首页 > 最新文献

Research Journal of Pharmaceutical Dosage Forms and Technology最新文献

英文 中文
Formulation and Development of Solid Dispersion System for Enhancement of Solubility and Dissolution Rate of Lovastatin 提高洛伐他汀溶解度和溶出率的固体分散体系的研制
Pub Date : 2023-08-05 DOI: 10.52711/0975-4377.2023.00028
Ashutosh Kumar Upadhyay, Naveen Gupta, Neeraj Sharma, Dharmendra S. Rajput, Ankita Shukla
The solubility and dissolution rate of Lovastatin, a drug used for the treatment of hyperlipidaemia. Lovastatin is a selective competitive inhibitor of HMG Co-A reductase. However, its absolute bioavailability is 5%. To increase the solubility of drug solid dispersion was prepared. Solid dispersion prepared with polymer in 1:5 ratios shows the presence of amorphous form confirmed by the characterization study. Solid dispersion preliminary solubility analysis was carried out for the selection of the carrier and solid dispersion was prepared with Hydroxy Propyl Methyl Cellulose (HPMC) and Methyl Cellulose (MC). These solid dispersions were analyzed for the solubility and in-vitro dissolution profile solid dispersion of drug with polymer has shown enhanced solubility with improved dissolution rate. Further FTIR, X-Ray studies were carried out. The present investigations showed that solubility of Lovastatin Sodium was markedly increased by its solid dispersion using PVP K30 as carrier. The formulation SDF8 containing (1:8) shows highest dissolution rate. Hence the solid dispersion a way is useful technique in providing fastest onset of action of Lovastatin Sodium as well as enhanced dissolution rate. The study also shows that dissolution rate of Lovastatin can be enhanced to considerable extent by solid dispersion technique with Polymer.
洛伐他汀的溶解度和溶解率,一种用于治疗高脂血症的药物洛伐他汀是HMG Co-A还原酶的选择性竞争性抑制剂。但其绝对生物利用度为5%。为提高药物的溶解度,制备了固体分散体。用聚合物按1:5的比例制备的固体分散体显示出非晶态的存在,表征研究证实了这一点。对固体分散体进行初步溶解度分析,选择载体,并以羟丙基甲基纤维素(HPMC)和甲基纤维素(MC)制备固体分散体。对这些固体分散体的溶解度和体外溶出谱进行了分析,表明药物与聚合物的固体分散体溶解度增强,溶出率提高。进一步进行了FTIR和x射线研究。本研究表明,以PVP K30为载体,洛伐他汀钠的固体分散能显著提高其溶解度。含(1:8)的配方SDF8溶出率最高。因此,固体分散法是洛伐他汀钠最快起效和提高溶出速度的有效技术。研究还表明,聚合物固体分散技术可以在很大程度上提高洛伐他汀的溶出速度。
{"title":"Formulation and Development of Solid Dispersion System for Enhancement of Solubility and Dissolution Rate of Lovastatin","authors":"Ashutosh Kumar Upadhyay, Naveen Gupta, Neeraj Sharma, Dharmendra S. Rajput, Ankita Shukla","doi":"10.52711/0975-4377.2023.00028","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00028","url":null,"abstract":"The solubility and dissolution rate of Lovastatin, a drug used for the treatment of hyperlipidaemia. Lovastatin is a selective competitive inhibitor of HMG Co-A reductase. However, its absolute bioavailability is 5%. To increase the solubility of drug solid dispersion was prepared. Solid dispersion prepared with polymer in 1:5 ratios shows the presence of amorphous form confirmed by the characterization study. Solid dispersion preliminary solubility analysis was carried out for the selection of the carrier and solid dispersion was prepared with Hydroxy Propyl Methyl Cellulose (HPMC) and Methyl Cellulose (MC). These solid dispersions were analyzed for the solubility and in-vitro dissolution profile solid dispersion of drug with polymer has shown enhanced solubility with improved dissolution rate. Further FTIR, X-Ray studies were carried out. The present investigations showed that solubility of Lovastatin Sodium was markedly increased by its solid dispersion using PVP K30 as carrier. The formulation SDF8 containing (1:8) shows highest dissolution rate. Hence the solid dispersion a way is useful technique in providing fastest onset of action of Lovastatin Sodium as well as enhanced dissolution rate. The study also shows that dissolution rate of Lovastatin can be enhanced to considerable extent by solid dispersion technique with Polymer.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136083315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design, Development and Formulation of Mucoadhesive In-situ Nasal Gel of Meperidine Hydrochloride 盐酸哌替啶原位黏附鼻凝胶的设计、研制及配方研究
Pub Date : 2023-05-18 DOI: 10.52711/0975-4377.2023.00018
Nausaba Moazzam, Naveen Gupta, N. Sharma, Dharmendra S. Rajput, Ankita Shukla
Mucoadhesive thermo reversible in-situ nasal gel of Meperidine HCl was designed and developed to sustain its release due to the increased nasal residence time of the formulation. Poloxamer 407 (PF 127) was selected as it has excellent thermo sensitive gelling properties. HPMCK4M was added to impart mucoadhesive to the formulation, and PEG 400 was used to enhance the drug release. 32 Factorial designs were employed to assess the effect of concentration of HPMCK4M and PEG 400 on the performance of in-situ nasal gel systematically and to optimize the formulation. Meperidine Hydrochloride is a centrally acting analgesic. It has 33% bioavailability due to its first pass effect and hence possesses problems in the development of oral sustained release formulations. An optimized in-situ nasal gel was evaluated for appearance, pH, drug content, gelation temperature, mucoadhesive force, viscosity and ex-vivo permeability of drug through nasal mucosa of a goat. Additionally, this formulation was proved to be safe as histopathological studies revealed no deleterious effect on nasal mucosa of a goat after prolonged exposure of 21 days to the optimized formulation. Thus the release of Meperidine Hydrochloride can be sustained if formulated in an in-situ nasal gel containing poloxamer 407 to achieve its prolonged action.
设计并开发了盐酸哌替啶原位热可逆黏附鼻凝胶,以维持其释放,因为制剂的鼻腔停留时间增加。选择poloxam407 (PF 127)是因为它具有优异的热敏胶凝性能。加入HPMCK4M增强黏合剂,加入PEG 400增强药物释放。采用32个因子设计,系统评价HPMCK4M和PEG 400浓度对原位鼻腔凝胶性能的影响,并对配方进行优化。盐酸哌替啶是一种中枢镇痛药。由于其首过效应,它具有33%的生物利用度,因此在口服缓释制剂的开发中存在问题。对优化后的原位鼻凝胶的外观、pH值、药物含量、凝胶温度、黏附力、粘度和药物通过山羊鼻粘膜的离体通透性进行了评价。此外,该配方被证明是安全的,因为组织病理学研究显示,在长时间暴露于优化配方21天后,对山羊的鼻黏膜没有有害影响。因此,如果在含有波洛沙姆407的原位鼻凝胶中配制以实现其延长作用,则盐酸哌啶的释放可以持续。
{"title":"Design, Development and Formulation of Mucoadhesive In-situ Nasal Gel of Meperidine Hydrochloride","authors":"Nausaba Moazzam, Naveen Gupta, N. Sharma, Dharmendra S. Rajput, Ankita Shukla","doi":"10.52711/0975-4377.2023.00018","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00018","url":null,"abstract":"Mucoadhesive thermo reversible in-situ nasal gel of Meperidine HCl was designed and developed to sustain its release due to the increased nasal residence time of the formulation. Poloxamer 407 (PF 127) was selected as it has excellent thermo sensitive gelling properties. HPMCK4M was added to impart mucoadhesive to the formulation, and PEG 400 was used to enhance the drug release. 32 Factorial designs were employed to assess the effect of concentration of HPMCK4M and PEG 400 on the performance of in-situ nasal gel systematically and to optimize the formulation. Meperidine Hydrochloride is a centrally acting analgesic. It has 33% bioavailability due to its first pass effect and hence possesses problems in the development of oral sustained release formulations. An optimized in-situ nasal gel was evaluated for appearance, pH, drug content, gelation temperature, mucoadhesive force, viscosity and ex-vivo permeability of drug through nasal mucosa of a goat. Additionally, this formulation was proved to be safe as histopathological studies revealed no deleterious effect on nasal mucosa of a goat after prolonged exposure of 21 days to the optimized formulation. Thus the release of Meperidine Hydrochloride can be sustained if formulated in an in-situ nasal gel containing poloxamer 407 to achieve its prolonged action.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75527306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and Evaluation of Conditioning Herbal Shampoo 调理草本香波的配方及评价
Pub Date : 2023-05-18 DOI: 10.52711/0975-4377.2023.00013
Laxman S Vijapur, Anita R. Desai, Gajanand G. Satbhai, Supriya P. Suragond, Bhagyashree V S, Farha Hassan
The study aimed to formulate a herbal shampoo and evaluate its physicochemical properties. The herbal shampoo was formulated by adding the extracts of amla, bhringraj, curry leaves, reetha and shikakaiin different proportions to water, methyl paraben was added and completely dissolved. To this 2% of carbopol-934 was added to form a gel. All extracts were weighed and dissolved to form a homogenous solution, lemon juice and citric acid was stirred properly with it. The evaluation parameters such as visual inspection, foaming ability, foaming stability, pH, dirt dispersion, measurement of surface tension, rheological evaluation and percentage of solid contents were performed to determine the physicochemical properties of formulated herbal shampoo. The formulated herbal shampoo was also evaluated for conditioning performance by administering a blind test to 30 student volunteers. It showed low surface tension, good foam stability after 5 min. The results indicated that the formulated shampoo was observed to be suitable for use and safe.
本研究旨在研制一种草药洗发水,并对其理化性质进行评价。将不同比例的苦楝叶、苦楝叶、咖喱叶、芦花叶和石竹叶提取物加入水中,加入对羟基苯甲酸甲酯并完全溶解,配制成草药洗发水。在此基础上加入2%的碳水化合物934形成凝胶。所有提取物称重并溶解成均匀溶液,柠檬汁和柠檬酸适当搅拌。通过目测、发泡能力、发泡稳定性、pH值、污垢分散度、表面张力测量、流变性评价和固含量百分比等评价参数来确定配方中草药洗发水的理化性能。通过对30名学生志愿者进行盲测,还对配方草药洗发水的调理性能进行了评估。结果表明,该洗发水表面张力低,5 min后泡沫稳定性好,使用安全。
{"title":"Formulation and Evaluation of Conditioning Herbal Shampoo","authors":"Laxman S Vijapur, Anita R. Desai, Gajanand G. Satbhai, Supriya P. Suragond, Bhagyashree V S, Farha Hassan","doi":"10.52711/0975-4377.2023.00013","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00013","url":null,"abstract":"The study aimed to formulate a herbal shampoo and evaluate its physicochemical properties. The herbal shampoo was formulated by adding the extracts of amla, bhringraj, curry leaves, reetha and shikakaiin different proportions to water, methyl paraben was added and completely dissolved. To this 2% of carbopol-934 was added to form a gel. All extracts were weighed and dissolved to form a homogenous solution, lemon juice and citric acid was stirred properly with it. The evaluation parameters such as visual inspection, foaming ability, foaming stability, pH, dirt dispersion, measurement of surface tension, rheological evaluation and percentage of solid contents were performed to determine the physicochemical properties of formulated herbal shampoo. The formulated herbal shampoo was also evaluated for conditioning performance by administering a blind test to 30 student volunteers. It showed low surface tension, good foam stability after 5 min. The results indicated that the formulated shampoo was observed to be suitable for use and safe.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83616163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing Bioequivalence Predictions with PAMPA Dissolution Using Formulations of Telmisartan 替米沙坦配方提高PAMPA溶出度的生物等效性预测
Pub Date : 2023-05-18 DOI: 10.52711/0975-4377.2023.00019
Joe Chou, R. Lai, Jason Chou, Shelly Fu, Hsin-Ai Tung
Traditionally, the pilot bioequivalence study is a generalpractice for generic drug development. However, due to its difficulty in differentiating the variation between subject and drug formulation for bioequivalence results. A new instrument called PAMPA Dissolution is proposed in this study to improve the correlation between in vitro and in vivo absorption forbioequivalence study. PAMPA Dissolution allows for the simultaneous measurement of drug dissolution (Cb) and permeation (Pe), two key parameters in oral drug absorption according to the validated equation F (drug absorbed) = Cb*Pe*Area. The use of Parallel Artificial Membrane Permeability Assay (PAMPA) eliminates the concern of subject variation. Biorelevant media further allows this device to simulate in vivo conditions closely. Brand and generic formulations of 40 mg telmisartan tablets were used in various studies to demonstrate the potential of PAMPA Dissolution in generic drug development. Bioequivalence predictions between brand and generic telmisartan from PAMPA Dissolution produced avalue(test/reference)for Cmax of 86.3% and a value for AUC of 91.4%, indicating that PAMPA Dissolution predictions conform with bioequivalence requirements. Other parameters such as stirring at different speeds and phospholipids concentrations for PAMPA are also included for optimal performance of the system. Based on these data, the PAMPA Dissolution system is reproducible, precise, and can therefore be applied in predicting bioequivalence study.
传统上,试点生物等效性研究是仿制药开发的一般做法。然而,由于生物等效性结果难以区分受试者和药物制剂之间的差异。本研究提出了一种新的PAMPA溶出度仪器,以提高生物等效性研究中体外和体内吸收的相关性。PAMPA溶出度可同时测定药物溶出度(Cb)和透入度(Pe)这两个口服药物吸收的关键参数,公式为F(药物吸收)= Cb*Pe*面积。平行人工膜透性测定(PAMPA)的使用消除了受试者变异的担忧。生物相关介质进一步使该设备能够密切模拟体内条件。在各种研究中使用了40mg替米沙坦片剂的品牌和仿制制剂,以证明PAMPA溶出度在仿制药开发中的潜力。PAMPA溶出度对品牌和仿制替米沙坦生物等效性预测的Cmax值(试验/参考)为86.3%,AUC值为91.4%,表明PAMPA溶出度预测符合生物等效性要求。其他参数,如以不同的速度搅拌和PAMPA的磷脂浓度也包括在系统的最佳性能。基于这些数据,PAMPA溶出度系统重复性好,精度高,可用于预测生物等效性研究。
{"title":"Enhancing Bioequivalence Predictions with PAMPA Dissolution Using Formulations of Telmisartan","authors":"Joe Chou, R. Lai, Jason Chou, Shelly Fu, Hsin-Ai Tung","doi":"10.52711/0975-4377.2023.00019","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00019","url":null,"abstract":"Traditionally, the pilot bioequivalence study is a generalpractice for generic drug development. However, due to its difficulty in differentiating the variation between subject and drug formulation for bioequivalence results. A new instrument called PAMPA Dissolution is proposed in this study to improve the correlation between in vitro and in vivo absorption forbioequivalence study. PAMPA Dissolution allows for the simultaneous measurement of drug dissolution (Cb) and permeation (Pe), two key parameters in oral drug absorption according to the validated equation F (drug absorbed) = Cb*Pe*Area. The use of Parallel Artificial Membrane Permeability Assay (PAMPA) eliminates the concern of subject variation. Biorelevant media further allows this device to simulate in vivo conditions closely. Brand and generic formulations of 40 mg telmisartan tablets were used in various studies to demonstrate the potential of PAMPA Dissolution in generic drug development. Bioequivalence predictions between brand and generic telmisartan from PAMPA Dissolution produced avalue(test/reference)for Cmax of 86.3% and a value for AUC of 91.4%, indicating that PAMPA Dissolution predictions conform with bioequivalence requirements. Other parameters such as stirring at different speeds and phospholipids concentrations for PAMPA are also included for optimal performance of the system. Based on these data, the PAMPA Dissolution system is reproducible, precise, and can therefore be applied in predicting bioequivalence study.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78582912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Design, Fabrication, and Analysis of Resveratrol and Piperine-Loaded Chitosan Nanoparticles with the Purpose of Providing an Enhanced Parkinson's Disease Treatment 白藜芦醇和胡椒碱负载壳聚糖纳米颗粒的设计、制造和分析,目的是提供增强帕金森病的治疗
Pub Date : 2023-05-18 DOI: 10.52711/0975-4377.2023.00017
Komal Nirale, Pallavi Wadaskar, Mukul Rajgure
Nanoformulation plays an essential function in emphasising the efficiency of reaching medications such as chemotherapeutic treatments and phytochemicals, and this significance is becoming increasingly recognised. In the course of this experiment, we focused on increasing the bioavailability of resveratrol lby loading it into nanoparticles. Doing so has the potential to reduce the toxicity that is a side effect of conventional formulation as well as minimise the amount of times a dose needs to be administered. The polymer, in its capacity as a carrier, plays a vital role in transporting the drug over the blood-brain barrier, which may be effective in bringing about the desired therapeutic effect. Piperine, acting as both a bio enhancer and an MAO inhibitor, has the potential to not only boost the effectiveness of resveratrol but also provide an additional mode of action that can be used to treat Parkinson's disease in a manner that is both efficient and effective. Additionally, piperine has the potential to be used in place of MAO-B inhibitors like selegline and rosagline. This provides a boost to the ongoing work on particle size in relation to two different medications and a polymer.
纳米制剂在强调化学疗法和植物化学物质等药物获得的效率方面发挥着重要作用,这种重要性正日益得到承认。在实验过程中,我们着重于通过将白藜芦醇装载到纳米颗粒中来提高其生物利用度。这样做有可能减少毒性,这是传统配方的副作用,并最大限度地减少剂量需要服用的次数。聚合物作为一种载体,在将药物运输过血脑屏障方面起着至关重要的作用,这可能有效地带来预期的治疗效果。这为正在进行的关于两种不同药物和聚合物的颗粒大小的研究提供了动力。
{"title":"Design, Fabrication, and Analysis of Resveratrol and Piperine-Loaded Chitosan Nanoparticles with the Purpose of Providing an Enhanced Parkinson's Disease Treatment","authors":"Komal Nirale, Pallavi Wadaskar, Mukul Rajgure","doi":"10.52711/0975-4377.2023.00017","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00017","url":null,"abstract":"Nanoformulation plays an essential function in emphasising the efficiency of reaching medications such as chemotherapeutic treatments and phytochemicals, and this significance is becoming increasingly recognised. In the course of this experiment, we focused on increasing the bioavailability of resveratrol lby loading it into nanoparticles. Doing so has the potential to reduce the toxicity that is a side effect of conventional formulation as well as minimise the amount of times a dose needs to be administered. The polymer, in its capacity as a carrier, plays a vital role in transporting the drug over the blood-brain barrier, which may be effective in bringing about the desired therapeutic effect. Piperine, acting as both a bio enhancer and an MAO inhibitor, has the potential to not only boost the effectiveness of resveratrol but also provide an additional mode of action that can be used to treat Parkinson's disease in a manner that is both efficient and effective. Additionally, piperine has the potential to be used in place of MAO-B inhibitors like selegline and rosagline. This provides a boost to the ongoing work on particle size in relation to two different medications and a polymer.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82585737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Formulation for Enhancement of Solubility and Dissolution Rate of Simvastatin using Solid Dispersion 固体分散剂提高辛伐他汀溶解度和溶出率的配方
Pub Date : 2023-05-18 DOI: 10.52711/0975-4377.2023.00024
Girijesh Kumar, Naveen Gupta, N. Sharma, Dharmendra S. Rajput, Ankita Shukla
Solid dispersion preliminary solubility analysis was carried out for the selection of the carrier and solid dispersion was prepared with Hydroxy Propyl Methyl Cellulose (HPMC) and Methyl Cellulose (MC). These solid dispersions were analyzed for the solubility and in-vitro dissolution profile solid dispersion of drug with polymer has shown enhanced solubility with improved dissolution rate. Further FTIR, X-Ray studies were carried out. The solubility and dissolution rate of Simvastatin, a drug used for the treatment of hyperlipidaemia. Simvastatin is a selective competitive inhibitor of HMG Co-A reductase. However its absolute bioavailability is 5%. To increase the solubility of drug solid dispersion was prepared. Solid dispersion prepared with polymer in 1:5 ratios shows the presence of amorphous form confirmed by the characterization study. The present investigations showed that solubility of Simvastatin Sodium was markedly increased by its solid dispersion using PVP K30 as carrier. The formulation SDF8 containing (1:8) shows highest dissolution rate. Hence the solid dispersion a way is useful technique in providing fastest onset of action of Simvastatin Sodium as well as enhanced dissolution rate. The study also shows that dissolution rate of Simvastatin can be enhanced to considerable extent by solid dispersion technique with Polymer.
对固体分散体进行初步溶解度分析,选择载体,并以羟丙基甲基纤维素(HPMC)和甲基纤维素(MC)制备固体分散体。对这些固体分散体的溶解度和体外溶出谱进行了分析,表明药物与聚合物的固体分散体溶解度增强,溶出率提高。进一步进行了FTIR和x射线研究。辛伐他汀的溶解度和溶出率,辛伐他汀是一种治疗高脂血症的药物辛伐他汀是HMG Co-A还原酶的选择性竞争性抑制剂。但其绝对生物利用度为5%。为提高药物的溶解度,制备了固体分散体。用聚合物按1:5的比例制备的固体分散体显示出非晶态的存在,表征研究证实了这一点。本研究表明,以PVP K30为载体,辛伐他汀钠的固体分散能显著提高其溶解度。含(1:8)的配方SDF8溶出率最高。因此,固体分散法是提供辛伐他汀钠最快起效和提高溶出速度的有用技术。研究还表明,聚合物固体分散技术可显著提高辛伐他汀的溶出速度。
{"title":"Formulation for Enhancement of Solubility and Dissolution Rate of Simvastatin using Solid Dispersion","authors":"Girijesh Kumar, Naveen Gupta, N. Sharma, Dharmendra S. Rajput, Ankita Shukla","doi":"10.52711/0975-4377.2023.00024","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00024","url":null,"abstract":"Solid dispersion preliminary solubility analysis was carried out for the selection of the carrier and solid dispersion was prepared with Hydroxy Propyl Methyl Cellulose (HPMC) and Methyl Cellulose (MC). These solid dispersions were analyzed for the solubility and in-vitro dissolution profile solid dispersion of drug with polymer has shown enhanced solubility with improved dissolution rate. Further FTIR, X-Ray studies were carried out. The solubility and dissolution rate of Simvastatin, a drug used for the treatment of hyperlipidaemia. Simvastatin is a selective competitive inhibitor of HMG Co-A reductase. However its absolute bioavailability is 5%. To increase the solubility of drug solid dispersion was prepared. Solid dispersion prepared with polymer in 1:5 ratios shows the presence of amorphous form confirmed by the characterization study. The present investigations showed that solubility of Simvastatin Sodium was markedly increased by its solid dispersion using PVP K30 as carrier. The formulation SDF8 containing (1:8) shows highest dissolution rate. Hence the solid dispersion a way is useful technique in providing fastest onset of action of Simvastatin Sodium as well as enhanced dissolution rate. The study also shows that dissolution rate of Simvastatin can be enhanced to considerable extent by solid dispersion technique with Polymer.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80324635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liposomes containing azithromycin and green tea as an anti-acne treatment: Formulation and Characterization 含有阿奇霉素和绿茶的脂质体作为抗痤疮治疗:配方和表征
Pub Date : 2023-05-18 DOI: 10.52711/0975-4377.2023.00016
Pallavi Wadaskar, Komal Nirale, Mukul Rajgure
Liposomes and other novel drug delivery carriers are highly adaptable, allowing for the distribution of a wide range of pharmacological compounds. The antibiotic azithromycin is widely regarded as the most effective treatment for acne. Lower efficacy or higher negative effects have led to decreased use of topical azithromycin. In this study, liposomes have been chosen because it is hypothesised that this may lessen the drug's side effects when used in conjunction with Azithromycin. Traditional herbal therapies have been intensively investigated as alternatives to conventional treatments for many ailments due to the possibility for side effects and antibiotic resistance from conventional pharmaceuticals. Thanks to its antibacterial qualities, green tea is one of the most effective natural therapies for acne. The lipid film hydration method was used to create drug-loaded liposomes, and the optimal component ratios were established. Liposomes were studied for their in-vitro drug release properties and characterised for their vesicle size, shape, encapsulation effectiveness, and drug content. Formulations F1 and F6, which included a 1:1 ratio of fat to cholesterol, showed the highest levels of encapsulation efficiency (69.5% and 66.2%, respectively) and in-vitro drug release (82.5 and 82.2 percent, respectively). Carbopol gel has been modified to include liposomal formulations, and the results have been compared to those of commercially available gels that do not use liposomes. Within 24 hours, the release of azithromycin (90.5%) was greater in the non liposomal marketed gel than in the liposomal gel (77.5% and 74.8%) of green tea. Green tea liposomes used in the formulation had a MIC value that was comparable to that of commercially available, non-liposomal gel. It was discovered that azithromycin was more effective than green tea in killing Micrococcus luteus.
脂质体和其他新型药物递送载体具有高度适应性,允许广泛的药理学化合物分布。抗生素阿奇霉素被广泛认为是治疗痤疮最有效的药物。较低的疗效或较高的负面影响导致减少使用局部阿奇霉素。在这项研究中,之所以选择脂质体,是因为假设脂质体与阿奇霉素联合使用时可能会减轻药物的副作用。由于传统药物可能产生副作用和抗生素耐药性,传统草药疗法作为许多疾病的传统治疗方法的替代品已被深入研究。由于其抗菌特性,绿茶是治疗痤疮最有效的自然疗法之一。采用脂膜水合法制备载药脂质体,并确定最佳配比。研究了脂质体的体外药物释放特性,并对其囊泡大小、形状、包封效果和药物含量进行了表征。脂肪与胆固醇比例为1:1的配方F1和F6具有最高的包封率(分别为69.5%和66.2%)和体外释药率(分别为82.5%和82.2%)。Carbopol凝胶已被修改以包括脂质体制剂,并且结果已与那些不使用脂质体的市售凝胶进行比较。24小时内,非脂质体凝胶中阿奇霉素的释放量(90.5%)高于绿茶脂质体凝胶(77.5%和74.8%)。配方中使用的绿茶脂质体的MIC值与市售的非脂质体凝胶相当。研究发现,阿奇霉素对黄体微球菌的杀伤效果优于绿茶。
{"title":"Liposomes containing azithromycin and green tea as an anti-acne treatment: Formulation and Characterization","authors":"Pallavi Wadaskar, Komal Nirale, Mukul Rajgure","doi":"10.52711/0975-4377.2023.00016","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00016","url":null,"abstract":"Liposomes and other novel drug delivery carriers are highly adaptable, allowing for the distribution of a wide range of pharmacological compounds. The antibiotic azithromycin is widely regarded as the most effective treatment for acne. Lower efficacy or higher negative effects have led to decreased use of topical azithromycin. In this study, liposomes have been chosen because it is hypothesised that this may lessen the drug's side effects when used in conjunction with Azithromycin. Traditional herbal therapies have been intensively investigated as alternatives to conventional treatments for many ailments due to the possibility for side effects and antibiotic resistance from conventional pharmaceuticals. Thanks to its antibacterial qualities, green tea is one of the most effective natural therapies for acne. The lipid film hydration method was used to create drug-loaded liposomes, and the optimal component ratios were established. Liposomes were studied for their in-vitro drug release properties and characterised for their vesicle size, shape, encapsulation effectiveness, and drug content. Formulations F1 and F6, which included a 1:1 ratio of fat to cholesterol, showed the highest levels of encapsulation efficiency (69.5% and 66.2%, respectively) and in-vitro drug release (82.5 and 82.2 percent, respectively). Carbopol gel has been modified to include liposomal formulations, and the results have been compared to those of commercially available gels that do not use liposomes. Within 24 hours, the release of azithromycin (90.5%) was greater in the non liposomal marketed gel than in the liposomal gel (77.5% and 74.8%) of green tea. Green tea liposomes used in the formulation had a MIC value that was comparable to that of commercially available, non-liposomal gel. It was discovered that azithromycin was more effective than green tea in killing Micrococcus luteus.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90618548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and Evaluation of Mucoadhesive In-situ Nasal Gel of Tramadol Hydrochloride 盐酸曲马多黏附原位鼻凝胶的研制及评价
Pub Date : 2023-05-18 DOI: 10.52711/0975-4377.2023.00022
Sushmita Vishwakarma, Naveen Gupta, N. Sharma, Dharmendra S. Rajput, Ankita Shukla
Tramadol Hydrochloride is a centrally acting analgesic. It has 33% bioavailability due to its first pass effect and hence possesses problems in the development of oral sustained release formulations. Muco-adhesive thermo reversible in-situ nasal gel of Tramadol HCl was designed and developed to sustain its release due to the increased nasal residence time of the formulation. Poloxamer 407(PF 127) was selected as it has excellent thermo sensitive gelling properties. HPMCK4M was added to impart muco-adhesive to the formulation, and PEG 400 was used to enhance the drug release. 32 Factorial designs were employed to assess the effect of concentration of HPMCK4M and PEG 400 on the performance of in-situ nasal gel systematically and to optimize the formulation. An optimized in-situ nasal gel was evaluated for appearance, pH, drug content, gelation temperature, mucoadhesive force, viscosity and ex-vivo permeability of drug through nasal mucosa of a goat. Additionally, this formulation was proved to be safe as histopathological studies revealed no deleterious effect on nasal mucosa of a goat after prolonged exposure of 21 days to the optimized formulation. Thus the release of Tramadol Hydrochloride can be sustained if formulated in an in-situ nasal gel containing poloxamer 407 to achieve its prolonged action.
盐酸曲马多是一种中枢镇痛药。由于其首过效应,它具有33%的生物利用度,因此在口服缓释制剂的开发中存在问题。设计并开发了曲马多盐酸原位热可逆黏附鼻凝胶,以维持其释放,因为制剂的鼻腔停留时间增加。选择poloxam407 (PF 127)是因为它具有优异的热敏胶凝性能。加入HPMCK4M增强黏附力,加入PEG 400增强释药。采用32个因子设计,系统评价HPMCK4M和PEG 400浓度对原位鼻腔凝胶性能的影响,并对配方进行优化。对优化后的原位鼻凝胶的外观、pH值、药物含量、凝胶温度、黏附力、粘度和药物通过山羊鼻粘膜的离体通透性进行了评价。此外,该配方被证明是安全的,因为组织病理学研究显示,在长时间暴露于优化配方21天后,对山羊的鼻黏膜没有有害影响。因此,如果在含有波洛沙姆407的原位鼻凝胶中配制以实现其延长作用,则盐酸曲马多的释放可以持续。
{"title":"Formulation and Evaluation of Mucoadhesive In-situ Nasal Gel of Tramadol Hydrochloride","authors":"Sushmita Vishwakarma, Naveen Gupta, N. Sharma, Dharmendra S. Rajput, Ankita Shukla","doi":"10.52711/0975-4377.2023.00022","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00022","url":null,"abstract":"Tramadol Hydrochloride is a centrally acting analgesic. It has 33% bioavailability due to its first pass effect and hence possesses problems in the development of oral sustained release formulations. Muco-adhesive thermo reversible in-situ nasal gel of Tramadol HCl was designed and developed to sustain its release due to the increased nasal residence time of the formulation. Poloxamer 407(PF 127) was selected as it has excellent thermo sensitive gelling properties. HPMCK4M was added to impart muco-adhesive to the formulation, and PEG 400 was used to enhance the drug release. 32 Factorial designs were employed to assess the effect of concentration of HPMCK4M and PEG 400 on the performance of in-situ nasal gel systematically and to optimize the formulation. An optimized in-situ nasal gel was evaluated for appearance, pH, drug content, gelation temperature, mucoadhesive force, viscosity and ex-vivo permeability of drug through nasal mucosa of a goat. Additionally, this formulation was proved to be safe as histopathological studies revealed no deleterious effect on nasal mucosa of a goat after prolonged exposure of 21 days to the optimized formulation. Thus the release of Tramadol Hydrochloride can be sustained if formulated in an in-situ nasal gel containing poloxamer 407 to achieve its prolonged action.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88822789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emulgel: A Novel Topical Drug Delivery 乳凝胶:一种新的局部给药方式
Pub Date : 2023-05-18 DOI: 10.52711/0975-4377.2023.00021
Likitha B, F. Sheeba, Yeshavantha Kumar, Shivanand K Mutta, H. S. Keerthy
Emulgel is a fresher class of dosage forms that are prepared by entrapment of large amounts of hydroalcoholic liquid into a network of colloidal solid particles. Emulgel formulations lead to faster drug release compared to ointments and creams. Even supposing gels have many uses but the major difficulty is to delivery of hydrophobic drugs. So, too weak these limitations, emulgels are unit ready. The mixture of gels and emulsions leads to emulgels. Emulsions it's an exact degree of elegance and is of course washed off whenever chosen, they take a high ability to penetrate the skin. Another necessary issue is to increase the drug release of even hydrophilicmedicine by creating w/o emulgel. Among the cluster of solid preparations, the utilization of emulgels has expandedin cosmetics and pharmaceutical preparations. Polymers act as emulsifiers and thickeners as a result of the gelling capability of those compounds permits the formulation of unchanging emulsions and creams by decreasing surface and surface tension and at a similar time increasing the viscosity of the aqueous part. Emulgels area unit is principally used for the delivery of analgesics, medication, anti-fungal, anti-acne medicine, and numerous cosmetic formulations. By applying an appropriate applied mathematics style dissimilar grades of emulgel area unit ready. There area unit numerous favorable properties like being thixotropic, emollient, greaseless, simply spreadable, simply removable, soluble, a longer period, non-staining, bio-friendly, clear and pleasing look. Many penetration enhancers will raise the result.
乳液是一种较新鲜的剂型,是通过将大量的氢酒精液体包裹在胶体固体颗粒的网络中而制备的。与软膏和面霜相比,凝胶制剂可以更快地释放药物。即使假设凝胶有很多用途,但主要的困难是运送疏水药物。所以,太弱这些限制,乳液单位准备好了。凝胶和乳剂的混合物产生乳剂。乳液是一种精确的优雅,当然,无论何时选择,都要洗掉,它们需要很高的穿透皮肤的能力。另一个必要的问题是通过制造无水凝胶来增加亲水性药物的药物释放。在固体制剂的集群中,凝胶在化妆品和药物制剂中的应用已经扩大。聚合物作为乳化剂和增稠剂,因为这些化合物的胶凝能力允许通过降低表面和表面张力来形成不变的乳液和霜,同时增加含水部分的粘度。凝胶区单位主要用于输送镇痛药,药物,抗真菌,抗痤疮药,和许多化妆品配方。采用适当的应用数学风格制备出不同等级的乳液。具有触变性、润肤性、无脂性、易涂抹性、易去除性、可溶性、使用寿命长、不染色、环保、干净美观等诸多优点。许多渗透增强剂会提高效果。
{"title":"Emulgel: A Novel Topical Drug Delivery","authors":"Likitha B, F. Sheeba, Yeshavantha Kumar, Shivanand K Mutta, H. S. Keerthy","doi":"10.52711/0975-4377.2023.00021","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00021","url":null,"abstract":"Emulgel is a fresher class of dosage forms that are prepared by entrapment of large amounts of hydroalcoholic liquid into a network of colloidal solid particles. Emulgel formulations lead to faster drug release compared to ointments and creams. Even supposing gels have many uses but the major difficulty is to delivery of hydrophobic drugs. So, too weak these limitations, emulgels are unit ready. The mixture of gels and emulsions leads to emulgels. Emulsions it's an exact degree of elegance and is of course washed off whenever chosen, they take a high ability to penetrate the skin. Another necessary issue is to increase the drug release of even hydrophilicmedicine by creating w/o emulgel. Among the cluster of solid preparations, the utilization of emulgels has expandedin cosmetics and pharmaceutical preparations. Polymers act as emulsifiers and thickeners as a result of the gelling capability of those compounds permits the formulation of unchanging emulsions and creams by decreasing surface and surface tension and at a similar time increasing the viscosity of the aqueous part. Emulgels area unit is principally used for the delivery of analgesics, medication, anti-fungal, anti-acne medicine, and numerous cosmetic formulations. By applying an appropriate applied mathematics style dissimilar grades of emulgel area unit ready. There area unit numerous favorable properties like being thixotropic, emollient, greaseless, simply spreadable, simply removable, soluble, a longer period, non-staining, bio-friendly, clear and pleasing look. Many penetration enhancers will raise the result.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78019372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Formulation and Evaluation as Sustain Released Nanoparticles for Zolmitriptan Hydrochloride for the enhanced Bioavailability and Better Therapeutic Action by using Chitosan as a Permeation Enhancer 壳聚糖作为缓释纳米粒提高盐酸佐米曲坦的生物利用度和治疗效果的制备及评价
Pub Date : 2023-05-18 DOI: 10.52711/0975-4377.2023.00015
Wajid Ahmad, Jaza Quazi
Chitosan was hydrophobically modified as N-Butyryl chitosan (NBC), N-Lauroyl chitosan (NLC) were synthesized and characterized by FTIR, NMR, XRD, modified chitosan were having about 14 % degree of substitution and varying solubility. Further evaluation of synthesized N-acyl chitosan to loaded Zolmitriptan HCl as nanoparticle by ionotropic method with cross linking by TPP. Average particle size, drug loading, entrapment efficiency and in-vitro mucoadhesion of Zolmitriptan HCl loaded nanoparticle was 150.7±3.3nm, 24.80±1.1% and 54.96±3.8% respectively, with positive zeta potential which were directly correlated with increases bulkiness of the acyl substitution in the modified chitosan except zeta potential was found inversely correlated. TEM and SEM imaging relieved spherical structure of nanoparticle. In vitro release of Zolmitriptan HCl in 1.2 pH HCl buffer and pH 7.4 phosphate buffer solutions showed biphasic release pattern best fitted with Korsmeyer’s-Peppas kinetics with fickian transport mechanism. Acylated chitosan showed sustained release reducing with increasing length of acyl group. Result of the present study showed that hydrophobically modified acylated chitosan can be useful for achieving sustained release controlled by acylation modification.
对壳聚糖进行疏水改性,合成了n -丁基壳聚糖(NBC)和n -月桂酰壳聚糖(NLC),并通过红外光谱、核磁共振、XRD对改性壳聚糖进行了表征,改性壳聚糖的取代度约为14%,溶解度变化较大。用离子化法和TPP交联进一步评价合成的n -酰基壳聚糖负载盐酸佐米曲坦作为纳米颗粒。负载盐酸佐米曲坦的纳米颗粒的平均粒径为150.7±3.3nm,载药量为24.80±1.1%,包封效率为54.96±3.8%,其zeta电位为正,与改性壳聚糖中酰基取代的体积增大直接相关,但zeta电位呈负相关。透射电镜和扫描电镜分析了纳米颗粒的球形结构。盐酸佐米曲坦在pH为1.2的盐酸缓冲液和pH为7.4的磷酸盐缓冲液中的体外释放表现出最符合Korsmeyer - peppas动力学的双相释放模式。羧化壳聚糖的缓释随酰基长度的增加而降低。本研究结果表明,疏水修饰的酰化壳聚糖可用于实现酰化修饰控制的缓释。
{"title":"Formulation and Evaluation as Sustain Released Nanoparticles for Zolmitriptan Hydrochloride for the enhanced Bioavailability and Better Therapeutic Action by using Chitosan as a Permeation Enhancer","authors":"Wajid Ahmad, Jaza Quazi","doi":"10.52711/0975-4377.2023.00015","DOIUrl":"https://doi.org/10.52711/0975-4377.2023.00015","url":null,"abstract":"Chitosan was hydrophobically modified as N-Butyryl chitosan (NBC), N-Lauroyl chitosan (NLC) were synthesized and characterized by FTIR, NMR, XRD, modified chitosan were having about 14 % degree of substitution and varying solubility. Further evaluation of synthesized N-acyl chitosan to loaded Zolmitriptan HCl as nanoparticle by ionotropic method with cross linking by TPP. Average particle size, drug loading, entrapment efficiency and in-vitro mucoadhesion of Zolmitriptan HCl loaded nanoparticle was 150.7±3.3nm, 24.80±1.1% and 54.96±3.8% respectively, with positive zeta potential which were directly correlated with increases bulkiness of the acyl substitution in the modified chitosan except zeta potential was found inversely correlated. TEM and SEM imaging relieved spherical structure of nanoparticle. In vitro release of Zolmitriptan HCl in 1.2 pH HCl buffer and pH 7.4 phosphate buffer solutions showed biphasic release pattern best fitted with Korsmeyer’s-Peppas kinetics with fickian transport mechanism. Acylated chitosan showed sustained release reducing with increasing length of acyl group. Result of the present study showed that hydrophobically modified acylated chitosan can be useful for achieving sustained release controlled by acylation modification.","PeriodicalId":20963,"journal":{"name":"Research Journal of Pharmaceutical Dosage Forms and Technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74023397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Research Journal of Pharmaceutical Dosage Forms and Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1